The next era of mobile technology will turn everyday Americans into “walking cameras” as AI-powered smart glasses monitor everything they see and hear, according to Qualcomm CEO Cristiano Amon.

During an appearance on “Mornings with Maria,” Amon described a future in which ultra-fast 6G networks will allow smart glasses to stream information to AI models in real time. He said the shift could reshape both the technology industry and everyday life. 

“6G is going to transform all of us into walking cameras because we have the ability to, everything that we see, send it to AI models that will interact with us and get intelligence right away,” Amon said Friday. “And that’s an exciting new device category.”

MICROSOFT CEO HAS A WARNING ABOUT THE AI RACE

Qualcomm President and CEO Cristiano Amon delivered the keynote address at Computex 2024 on June 3, 2024, in Taipei, Taiwan. (I-Hwa Cheng/AFP via Getty Images / Getty Images)

Qualcomm is known for creating technology inside devices such as smartphones, allowing them to connect to the internet. Earlier this week, Qualcomm announced its latest partnership with Meta to support the company’s rapidly growing computing needs.

Amon pointed to smart glasses as a key device for the future, saying they allow people to interact with technology close to their faces while AI processes what users see and hear.

BESSENT LAYS OUT 5 PRINCIPLES GUIDING TRUMP ADMIN’S APPROACH TO ECONOMIC STATECRAFT

“There’s a very interesting thing about glasses, and Meta is correct, and there’s many other companies investing in this,” he said. 

Meta CEO Mark Zuckerberg wore a pair of Meta Ray-Ban Display AI smart glasses during the Meta Connect event on Sept. 17, 2025, in Menlo Park, California. Meta introduced its first smart glasses featuring a built-in display as part of its expanding we (David Paul Morris/Bloomberg via Getty Images / Getty Images)

“As we humans start to interact with the computers the way we interact with ourselves, glasses is a very important real estate because it’s close to our eyes, our ears, our mouth. And AI is [going to] see what we see, hear what we hear, read what we read. And then you have this intelligence very quickly.”

JEFF BEZOS PREDICTS AI WILL CREATE A LABOR SHORTAGE, NOT REPLACE HUMAN WORKERS ACROSS THE ECONOMY

Meta, Google and Apple have all invested in developing their own smart glasses, with newer models incorporating artificial intelligence. On Tuesday, Meta announced a new line of lower-cost AI glasses powered by the company’s AI technology, Muse Spark. 

A man tried on AI smart glasses during the Mobile World Congress in Shanghai on June 24, 2026. (Hector Retamal/AFP via Getty Images / Getty Images)

CLICK HERE TO GET FOX BUSINESS ON THE GO

Qualcomm has also expanded its focus into data centers and AI software. It introduced a new “Dragonfly C1000” central processing unit that it says Meta is using. The company also plans to acquire AI startup Modular.

“I was reading a lot of the analyst reports from Investor Day, and there’s one headline that really, I really liked it and it caught my attention. There’s a headline that said, ’This is not your father’s Qualcomm anymore,’” Amon said of the changes. “And I think that’s kind of the story of the company.”

Abbott Laboratories shares advanced more than 1.82 percent on Friday, closing at $94.90 after gaining $1.70, as investors responded positively to the company’s consistent growth in medical devices and diagnostics.

The gain reflected confidence in Abbott’s diversified healthcare portfolio spanning nutrition, diagnostics, medical devices and pharmaceuticals. The company has demonstrated resilience across economic cycles through its focus on essential healthcare products and innovation.

Abbott’s FreeStyle Libre continuous glucose monitoring system has driven significant growth in its diabetes care business. The technology has transformed diabetes management for millions of patients worldwide.

The company’s structural heart devices and electrophysiology products have shown strong performance as minimally invasive procedures gain adoption. Its broad product portfolio provides stability while high-growth segments fuel expansion.

Business Performance and Strategy

Abbott operates through four main segments: nutrition, diagnostics, established pharmaceuticals and medical devices. This diversification reduces reliance on any single market or product category.

Nutrition products, including Similac and Ensure, serve infant and adult populations with specialized formulations. The segment benefits from demographic trends and health consciousness.

Diagnostics solutions range from laboratory instruments to rapid testing kits. The company’s molecular and point-of-care testing capabilities support various healthcare settings.

Established pharmaceuticals focus on branded generic medicines in emerging markets. This business provides stable revenue with growth potential in developing economies.

Medical devices encompass cardiovascular, neuromodulation and diabetes care products. Technological innovation and clinical evidence support adoption of these therapies.

Innovation and Product Development

Abbott continues investing in research and development to advance its product pipeline. Recent innovations in glucose monitoring, heart valves and diagnostic testing have expanded treatment options.

The company’s focus on minimally invasive procedures aligns with healthcare industry trends toward reduced recovery times and lower costs. Its structural heart portfolio has achieved strong clinical results.

Diabetes care innovations have improved patient quality of life through continuous monitoring and automated insulin delivery systems. These technologies represent significant advances in chronic disease management.

Abbott’s diagnostic platforms support rapid and accurate testing across various medical conditions. Its ability to deliver reliable results in diverse settings enhances its value proposition.

Market Position and Competition

Abbott maintains strong positions in multiple healthcare categories through brand reputation and technological leadership. Its global presence supports revenue diversification across regions.

Competition varies by segment, with specialized players challenging in specific areas. Abbott’s broad portfolio and innovation track record provide competitive advantages.

International expansion, particularly in emerging markets, offers growth opportunities. The company’s experience navigating different regulatory environments supports successful market entry.

Supply chain management and manufacturing excellence ensure product availability and quality. Abbott’s global operations require careful coordination to maintain standards.

Investment Considerations

Abbott’s share price performance reflects investor appreciation for its consistent growth and dividend reliability. The company’s healthcare focus provides defensive characteristics in various economic environments.

The stock appeals to investors seeking exposure to medical technology and consumer healthcare trends. Its diversified business model and strong cash flow support positive long-term outlooks.

Risks include regulatory changes, competitive pressures and healthcare spending constraints. Abbott’s innovation pipeline and global reach provide some mitigation against these factors.

Analysts generally maintain positive views, citing the company’s execution capabilities and market opportunities. Continued growth in key segments could support further positive sentiment.

Industry Trends

The healthcare industry continues evolving with emphasis on personalized medicine, digital health and cost efficiency. Abbott’s focus on innovative medical devices and diagnostics aligns with these trends.

Aging populations in developed markets increase demand for chronic disease management solutions. Abbott’s diabetes and cardiovascular products address important needs in this demographic shift.

Emerging markets offer growth opportunities as healthcare infrastructure expands and middle classes grow. Abbott’s experience in these regions supports successful market penetration.

Technological convergence in healthcare creates opportunities for integrated solutions. Abbott’s combination of devices, diagnostics and pharmaceuticals positions it to participate in this evolution.

Future Outlook

Abbott’s strategic direction focuses on innovation, global expansion and operational excellence. Its ability to execute on these priorities will influence long-term performance.

The company continues investing in research and development while maintaining financial discipline. Its balance of growth and profitability supports sustainable success.

Investors will monitor upcoming financial results and product developments for signs of continued momentum. Management guidance will provide insight into execution priorities and market conditions.

The healthcare sector’s fundamental demand drivers remain strong. Abbott’s market leadership, innovation capabilities and global presence position it for sustained relevance and growth.

As the company advances its product portfolio and market reach, its contribution to healthcare improvement will expand. Abbott’s progress will be watched closely by patients, healthcare providers and investors worldwide.

Union Pacific Corp. shares advanced more than 0.76 percent on Friday, closing at $269.76 after gaining $2.03, as investors responded positively to the company’s operational performance and industry conditions supporting freight transportation.

The gain reflected confidence in Union Pacific’s position as a major railroad operator with extensive network coverage across the western United States. The company’s focus on efficiency, safety and customer service has supported consistent performance in the freight transportation sector.

Union Pacific has reported stable volume growth across various commodity categories, with particular strength in certain industrial and consumer goods. Its ability to manage costs while maintaining service quality has contributed to financial results.

The railroad’s strategic initiatives include network optimization, technology investment and sustainability efforts. These programs aim to enhance operational efficiency and environmental performance while supporting long-term growth.

Operational Performance

Union Pacific operates one of North America’s largest railroad networks, connecting western markets with major ports and population centers. Its extensive track mileage and intermodal capabilities support diverse freight transportation needs.

The company has focused on precision scheduled railroading principles to improve efficiency and asset utilization. These operational improvements have enhanced velocity and reduced costs.

Safety performance remains a priority, with investments in technology and training supporting incident reduction. Union Pacific’s commitment to safety culture contributes to operational reliability and regulatory compliance.

Customer service enhancements include digital tools and tracking capabilities that improve transparency and efficiency for shippers. These investments strengthen relationships and competitive positioning.

Commodity and Market Trends

Union Pacific transports various commodities including agricultural products, energy, industrial goods and consumer items. Its performance reflects broader economic activity and trade patterns.

Agricultural shipments benefit from domestic production and export demand. Energy transportation includes crude oil, refined products and coal, with varying trends based on market conditions.

Industrial and consumer goods provide stable volume with growth potential tied to economic expansion. Intermodal transportation of containers supports international trade and domestic distribution.

The company’s network advantages in serving western ports and manufacturing centers support its market position. Strategic partnerships with other railroads and transportation providers expand service offerings.

Financial Performance and Strategy

Union Pacific has maintained solid financial results with revenue growth and margin stability. Its ability to adjust pricing and manage costs has supported profitability despite volume fluctuations.

The company’s capital investment program focuses on network maintenance, capacity expansion and technology upgrades. These investments support long-term operational performance and safety.

Shareholder returns through dividends and share repurchases reflect strong cash flow generation. Union Pacific’s financial discipline supports both growth investment and capital return.

Strategic initiatives include network optimization and service quality improvements. The company’s focus on operational excellence drives efficiency and customer satisfaction.

Industry Context

The railroad industry plays a vital role in American freight transportation, moving goods efficiently across long distances. Rail’s fuel efficiency and capacity advantages support its importance in supply chains.

Competition from trucking and other modes influences pricing and service offerings. Railroads’ ability to handle high-volume, long-haul shipments provides competitive edges in certain markets.

Regulatory oversight and safety standards shape industry operations. Union Pacific’s compliance and safety performance support its operating authority and reputation.

Sustainability initiatives across the industry address environmental concerns and stakeholder expectations. Rail’s relatively low carbon footprint compared to trucking supports its role in sustainable transportation.

Investment Considerations

Union Pacific’s share price performance reflects investor appreciation for its consistent execution and dividend reliability. The stock’s defensive characteristics in the transportation sector provide stability.

The company offers exposure to economic activity and trade flows with operational leverage. Its valuation reflects expectations for steady growth and efficient capital deployment.

Risks include economic slowdowns affecting freight volumes, fuel price volatility and regulatory changes. Union Pacific’s diversified commodity exposure and operational efficiency help mitigate these risks.

Longer-term investors value the company’s essential infrastructure role and consistent returns. Its ability to adapt to changing transportation needs supports sustained performance.

Future Outlook

Union Pacific’s strategic direction focuses on operational excellence, network optimization and customer service. Its ability to execute on these priorities will influence long-term performance.

The company continues investing in technology, infrastructure and sustainability initiatives. These investments support efficiency, safety and environmental performance.

Investors will monitor upcoming quarterly results for volume trends, pricing realization and cost management. Management guidance will provide insight into economic conditions and strategic execution.

The freight transportation industry’s fundamental role in the economy supports long-term demand. Union Pacific’s network strength, operational capabilities and customer relationships position it for continued success.

As the company advances its technology and sustainability initiatives, its contribution to efficient and environmentally responsible transportation will expand. Union Pacific’s progress will be watched closely by customers, regulators and investors.

This article was written by

Follow

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

The zones in York, Scarborough and Selby are built around job creation, housing and regeneration

Three mayoral development zones are to be created across York and North Yorkshire in a bid to boost jobs, housing and regeneration.

The development zones in Scarborough, Selby and the centre of York allow the area’s elected mayor to take a lead in bringing together developers, landowners and the local authority to attract private sector investment and align public sector funding.

An initial £10m MDZ regeneration fund has been proposed to accelerate the next phases of development and to unlock further Government and private investment.

The Selby Growth Zone will bring together major employment sites across the south of the are in a bid to create more than 7,000 new jobs in the Selby area. The York Central zone will aim to speed up the delivery of 2,500 homes and a central business district while in Scarborough, there will be measures to improve the town centre, bring forward leisure and tourism development and develop thousands of new homes.

Mayor David Skaith said: “This is about using the full powers available to the mayor through devolution to making a real difference to people’s everyday lives; good jobs, affordable homes, and thriving communities.

“The three areas that will become MDZs have the ability to deliver thousands of new homes, unlock thousands of new and better jobs, and attract billions of pounds of investment into our region. Some of the sites are ready to go and just need that final push, others need the final pieces of investment to get them going. Each MDZ will tailored to get development going and delivered quicker.”

North Yorkshire Council’s leader, Coun Carl Les, said: “We are committed to bringing the best possible opportunities for our communities in North Yorkshire, whether that be better career prospects, the chance to own their own home or regenerating our towns and villages.

“The proposed Mayoral Development Zones are due to offer the opportunity to build on the work we have been undertaking to support all areas of the economy in places such as Scarborough, from the leisure and tourism sectors to the harbour, fishing and other marine activities such as the off-shore windfarm industry.

“Whether that is the prospect of bringing 7,000 new jobs to the Selby area or creating thousands of new homes and new leisure and tourism opportunities to regenerate Scarborough, this will be so important to help build on our ambitions.

“We will continue to work closely within the combined authority to make sure that these plans do bring real benefits to our residents and businesses in both the Scarborough and Selby areas, as well as ensuring the positive impact can be felt elsewhere in the county.”

Coun Claire Douglas, leader of City of York Council, said: “York Central is one of the country’s most exciting regeneration projects. With new affordable homes and well-paid jobs, lots of new commercial and retail space, new parks and much more, it presents a transformational opportunity for York and the wider region.

“We want to ensure everyone in the city feels the benefits of this major investment. It must offer opportunity and must work for everyone, and this latest announcement from the mayor is welcome support for that vision.”

The report will be discussed at the York and North Yorkshire Combined Authority Cabinet meeting next week.